BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 14730100)

  • 1. Effects of classic and newer antidepressants on the oxidation pathways of caffeine in rat liver. In vitro study.
    Daniel WA; Kot M; Wójcikowski J
    Pol J Pharmacol; 2003; 55(6):1045-53. PubMed ID: 14730100
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of antidepressant drugs on the activity of cytochrome P-450 measured by caffeine oxidation in rat liver microsomes.
    Danie WA; Syrek M; Ryłko Z; Wójcikowski J
    Pol J Pharmacol; 2001; 53(4):351-7. PubMed ID: 11990081
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of classic and atypical neuroleptics on caffeine oxidation in rat liver microsomes.
    Daniel WA; Kot M; Wójcikowski J
    Pol J Pharmacol; 2003; 55(6):1055-61. PubMed ID: 14730101
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of phenothiazine neuroleptics on the rate of caffeine demethylation and hydroxylation in the rat liver.
    Daniel WA; Syrek M; Ryłko Z; Kot M
    Pol J Pharmacol; 2001; 53(6):615-21. PubMed ID: 11985335
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolism of the antidepressant mirtazapine in vitro: contribution of cytochromes P-450 1A2, 2D6, and 3A4.
    Störmer E; von Moltke LL; Shader RI; Greenblatt DJ
    Drug Metab Dispos; 2000 Oct; 28(10):1168-75. PubMed ID: 10997935
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relative contribution of rat cytochrome P450 isoforms to the metabolism of caffeine: the pathway and concentration dependence.
    Kot M; Daniel WA
    Biochem Pharmacol; 2008 Apr; 75(7):1538-49. PubMed ID: 18279840
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Caffeine metabolism during prolonged treatment of rats with antidepressant drugs.
    Kot M; Wójcikowski J; Daniel WA
    Pharmacol Rep; 2007; 59(6):727-33. PubMed ID: 18195463
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of human cytochrome P450 isoforms involved in the stereoselective metabolism of mianserin enantiomers.
    Koyama E; Chiba K; Tani M; Ishizaki T
    J Pharmacol Exp Ther; 1996 Jul; 278(1):21-30. PubMed ID: 8764331
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of short- and long-term treatment with antidepressant drugs on the activity of rat CYP2A in the liver.
    Haduch A; Wójcikowski J; Daniel WA
    Pharmacol Rep; 2005; 57(6):774-81. PubMed ID: 16382196
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of selective cytochrome P-450 inhibitors on the metabolism of thioridazine. In vitro studies.
    Daniel WA; Syrek M; Haduch A
    Pol J Pharmacol; 1999; 51(5):435-42. PubMed ID: 10817545
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Direct and indirect interactions between antidepressant drugs and CYP2C6 in the rat liver during long-term treatment.
    Daniel WA; Haduch A; Syrek M; Boksa J
    Eur Neuropsychopharmacol; 2006 Dec; 16(8):580-7. PubMed ID: 16503401
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quinolone inhibition of cytochrome P-450-dependent caffeine metabolism in human liver microsomes.
    Fuhr U; Wolff T; Harder S; Schymanski P; Staib AH
    Drug Metab Dispos; 1990; 18(6):1005-10. PubMed ID: 1981505
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The biotransformation of clomipramine in vitro, identification of the cytochrome P450s responsible for the separate metabolic pathways.
    Nielsen KK; Flinois JP; Beaune P; Brøsen K
    J Pharmacol Exp Ther; 1996 Jun; 277(3):1659-64. PubMed ID: 8667235
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition and possible induction of rat CYP2D after short- and long-term treatment with antidepressants.
    Daniel WA; Haduch A; Wójcikowski J
    J Pharm Pharmacol; 2002 Nov; 54(11):1545-52. PubMed ID: 12495558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of rat liver CYP2D in vitro and after 1-day and long-term exposure to neuroleptics in vivo-possible involvement of different mechanisms.
    Daniel WA; Haduch A; Wójcikowski J
    Eur Neuropsychopharmacol; 2005 Jan; 15(1):103-10. PubMed ID: 15572279
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The inhibitory effect of tannic acid on cytochrome P450 enzymes and NADPH-CYP reductase in rat and human liver microsomes.
    Yao HT; Chang YW; Lan SJ; Yeh TK
    Food Chem Toxicol; 2008 Feb; 46(2):645-53. PubMed ID: 17950511
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of ketoconazole on hepatic oxidative drug metabolism in the rat in vivo and in vitro.
    Meredith CG; Maldonado AL; Speeg KV
    Drug Metab Dispos; 1985; 13(2):156-62. PubMed ID: 2859162
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of antidepressant drugs on cytochrome P450 2C11 (CYP2C11) in rat liver.
    Wójcikowski J; Haduch A; Daniel WA
    Pharmacol Rep; 2013; 65(5):1247-55. PubMed ID: 24399720
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biotransformation of caffeine, paraxanthine, theophylline, and theobromine by polycyclic aromatic hydrocarbon-inducible cytochrome(s) P-450 in human liver microsomes.
    Campbell ME; Grant DM; Inaba T; Kalow W
    Drug Metab Dispos; 1987; 15(2):237-49. PubMed ID: 2882985
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of tricyclic antidepressants, selective serotonin reuptake inhibitors (SSRIs) and newer antidepressant drugs on the activity and level of rat CYP3A.
    Haduch A; Wójcikowski J; Daniel WA
    Eur Neuropsychopharmacol; 2006 Apr; 16(3):178-86. PubMed ID: 16246530
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.